Advertisement
ResearchIn-Press PreviewCell biologyNeuroscience
Open Access |
10.1172/JCI193407
1Dept. of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, United States of America
2Dept. of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, United States of America
Find articles by Siddu, A. in: PubMed | Google Scholar
1Dept. of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, United States of America
2Dept. of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, United States of America
Find articles by Natale, S. in: PubMed | Google Scholar
1Dept. of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, United States of America
2Dept. of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, United States of America
Find articles by Wong, C. in: PubMed | Google Scholar
1Dept. of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, United States of America
2Dept. of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, United States of America
Find articles by Shaye, H. in: PubMed | Google Scholar
1Dept. of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, United States of America
2Dept. of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, United States of America
Find articles by Südhof, T. in: PubMed | Google Scholar
Published September 30, 2025 - More info
Whether amyloid-β (Aβ) peptides are synaptogenic or synaptotoxic remains a pivotal open question in Alzheimer’s disease research. Here, we chronically treated human neurons with precisely controlled concentrations of chemically defined synthetic Aβ40, Aβ42, and Aβ42arctic peptides that exhibit distinct aggregation propensities. Remarkably, chronic exposure of human neurons to free Aβ40 at higher concentrations or to free Aβ42 at lower concentrations potently promoted synapse formation. In contrast, aggregated Aβ42 or Aβ42arctic at higher concentrations were neurotoxic and synaptotoxic. The synaptotoxic effects of Aβ peptides manifested as an initial contraction of the synaptic vesicle cluster followed by synapse loss. Aβ40 and Aβ42 peptides with scrambled or inverted sequences were inactive. Thus, our experiments reveal that Aβ peptides exhibit an aggregation-dependent functional dichotomy that renders them either synaptogenic or synaptotoxic, thereby providing insight into how Aβ peptides straddle a thin line between physiological synapse organization and pathological synapse disruption. Among others, our data suggest that Alzheimer’s disease therapies might aim to shift the balance of Aβ peptides from the aggregated to the free state instead of suppressing all Aβ peptides.